DCM Shriram Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 3,784.67 Cr (+9.50% YoY) and PAT growth of +42.90% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 28, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 3,784.67 Cr (+9.50% YoY) |
| PAT (Q1) | Rs. 692.75 Cr (+42.90% YoY) |
| EBITDA margin | 9.62% (+19 bps YoY) |
| EPS (Q1) | Rs. 44.42 (+447.20% YoY) |
| Market cap | Rs. 16,385.87 Cr |
| CMP | Rs. 1,049.90 |
Revenue grew 9.5% YoY with normalized PAT up 42.9%, driven by the Chemicals & Vinyl segment and new ECH plant. However, margin pressures in Fertiliser and a sharp Bioseed decline are concerns, while one-time tax credits inflated reported PAT. The company maintains a strong balance sheet with improving leverage.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now